Back
Nippon Building Fund, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
45
NBFJF
Nippon Building Fund, Inc.
Last Price:
$934.19
Seasonality Move:
10.12%
Sell
31
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Sell
45
Nippon Building Fund, Inc. (NBFJF)
is a Sell
Is Nippon Building Fund, Inc. a Buy, Sell or Hold?
-
The current Nippon Building Fund, Inc. [NBFJF] share price is $934.19. The Score for NBFJF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NBFJF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBFJF Stock Price Chart
What is Nippon Building Fund, Inc.'s stock price today?
-
The Nippon Building Fund, Inc. share price today is $934.19The current trend is relatively stagnant and NBFJF is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
NBFJF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 27.28 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (934.19 - 934.19) | Sell |
| Bollinger Bands (100): | (921.73 - 962.69) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.42 | Sell |
| Relative Strength Index (14 RSI): | 32.25 | Sell |
| Chaikin Money Flow: | -36886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.08 - 86.32) | Sell |
| Bollinger Bands (100): | (45.17 - 89.09) | Sell |
NBFJF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 934.19 | Sell |
| 20-day SMA: | 934.19 | Sell |
| 50-day SMA: | 934.19 | Sell |
| 200-day SMA: | 915.65 | Buy |
| 8-day EMA: | 934.19 | Sell |
| 20-day EMA: | 934.2 | Sell |
| 50-day EMA: | 934.95 | Sell |
| 200-day EMA: | 943.5 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.2 | Sell |
| 20-day SMA: | 79.37 | Sell |
| 50-day SMA: | 82.12 | Sell |
| 200-day SMA: | 52.13 | Buy |
| 8-day EMA: | 72.25 | Sell |
| 20-day EMA: | 76.67 | Sell |
| 50-day EMA: | 77.13 | Sell |
| 200-day EMA: | 56.56 | Buy |
Nippon Building Fund, Inc. Earnings Growth & NBFJF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Nippon Building Fund, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||